Established Los Angeles Dermatology Practice, 37 Years in an Affluent Market

$2.2M

Revenue

$1.4M

SDE

2.1x

Multiple

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a dermatology practice that has operated in an affluent pocket of Los Angeles since 1989, giving it 37 years of continuous operating history and a deeply seasoned patient base. On $2.21M of revenue it throws off $1.36M in cash flow, a 61% owner-earnings margin that is exceptional even by medical-practice standards and reflects both the pricing power of dermatology and the discretionary skin-care mix that tends to accompany wealthy Los Angeles clientele.

Dermatology is one of the more durable specialties in medicine. It blends recurring medical needs (skin cancer screening, chronic conditions, prescription management) with high-margin cash-pay cosmetic services (injectables, lasers, aesthetics) that an affluent LA patient panel continues to fund even in soft economies. The result is a returning patient base that comes back on predictable cadences rather than one-off transactions.

The headline risk is squarely the owner. At a 2.06x cash flow multiple the practice looks cheap on paper, but that discount almost always signals heavy dependence on a single treating physician whose personal patient relationships and clinical production drive the numbers. The buyer economics hinge entirely on whether that provider revenue transfers, which is why the low multiple should be read as a warning label rather than a bargain until proven otherwise.

Why we like it

Earnings quality is outstanding on the surface: $1.36M of cash flow on $2.21M of revenue is a 61% margin, which is rare and points to a favorable cash-pay cosmetic mix layered on top of reimbursed medical dermatology. The blend of insurance and elective aesthetic revenue smooths out payer risk while keeping realized rates high.
The moat is time and location. Thirty-seven years in an affluent LA neighborhood builds referral density, brand trust, and a returning patient panel that is very hard to replicate with a cold start. Established dermatology practices in wealthy zip codes enjoy waitlists and repeat visits rather than perpetual customer acquisition.
Market tailwinds are strong and structural. Aesthetic dermatology, injectables, and skin-cancer screening all grow with an aging, image-conscious, high-income population, and Los Angeles indexes heavily toward elective cosmetic spend. Demand for these services has proven resilient across cycles.
The revenue is genuinely recurring in the way that matters: patients return on clinical cadences for chronic conditions, screenings, and repeat aesthetic treatments like injectables that need refreshing every few months. This produces predictable, defensible visit volume rather than one-time transactions.
At 2.06x cash flow the price is well below typical medical-practice multiples, leaving meaningful margin of safety IF provider revenue transfers. For a buyer who can recruit or retain treating physicians, the entry price offers real downside protection relative to the earnings base.

How to improve it

Lock down clinical continuity immediately by negotiating an employment or medical-director agreement that keeps the selling physician producing for 12 to 24 months, with earnout tied to patient retention. Nothing else matters until provider revenue is proven to survive the transition.
Recruit one or two associate providers (physician, PA, or NP) in the first 90 days to build redundancy and expand capacity beyond a single owner-doctor. This de-risks key-person dependence and unlocks additional appointment slots that the affluent LA demand base can likely fill.
Expand the cash-pay aesthetics line, since it carries the highest margins and no payer friction. Add or optimize injectables, laser, and skincare-product retail, and package memberships or treatment plans to convert episodic visits into predictable recurring revenue.
Implement a modern recall and reactivation system to bring lapsed patients back for annual skin checks and repeat cosmetic treatments. A returning panel of this age almost certainly has thousands of dormant records worth systematically re-engaging.
Optimize payer mix and coding on the medical side to capture full reimbursement, then audit chair utilization and scheduling density. Small improvements in provider productivity and collections drop almost entirely to the bottom line at these margins.
Add a light digital front door: online booking, targeted local paid search for high-value aesthetic procedures, and reputation management. In an image-driven LA market, ranking and reviews directly drive high-ticket cash-pay bookings.
Evaluate a second location or satellite in an adjacent affluent submarket once provider bench is built. The brand and playbook are proven over 37 years, and geographic expansion is a cleaner growth lever than squeezing more from one office.

Diligence notes

Quantify exactly how much of the $1.36M cash flow is produced by the selling physician personally versus transferable systems and staff. The 2.06x multiple strongly implies single-provider dependence, and you must model the revenue that walks out the door if the owner leaves.
Break revenue into medical (insurance-reimbursed) versus cosmetic (cash-pay) and pull the payer mix, top procedures, and realized rates. The margin story lives or dies on the aesthetics contribution, and you need to confirm it is durable and not driven by one or two lucrative referral sources.
Verify the SDE add-backs and normalize physician compensation to a market clinical wage. A buyer who must pay a replacement dermatologist a fair salary will see cash flow drop materially, so the true post-transition earnings, not the headline number, should anchor valuation.
Confirm licensing, malpractice history, and California corporate-practice-of-medicine compliance, including how a non-physician buyer would structure ownership via an MSO. These regulatory constraints can materially reshape the deal and must be cleared before close.
Assess the lease and location economics in this affluent LA area, since prime real estate carries high occupancy cost and any relocation would jeopardize the patient base built over 37 years. Confirm assignable lease terms and remaining runway.
Review patient retention metrics, recall rates, and any concentration in referral relationships or a small number of high-value cosmetic patients. Understand whether demand is broad-based or dependent on the owner's personal reputation.

Source

Originally listed on DealStream. View original listing →